marijuana stock news

Chuma Holdings, Inc. (CHUM)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Feb 28, 2015 Nov 30, 2014 Aug 31, 2014 May 31, 2014
Total Revenue 64   67   34   –  
Cost of Revenue
Gross Profit 64   67   34   –  
Operating Expenses
Research Development
Selling General and Administrative 115 1,017 497 133
Non Recurring 4,014 22
Others 0 0 0 0
Total Operating Expenses
Operating Income or Loss (4,065) (972) (464) (133)
Income from Continuing Operations
Total Other Income/Expenses Net 518 12
Earnings Before Interest And Taxes (4,065) (454) (452) (133)
Interest Expense 7 7 8 8
Income Before Tax (4,071) (461) (459) (140)
Income Tax Expense
Minority Interest
Net Income From Continuing Ops (4,071) (461) (459) (140)
Non-recurring Events
Discontinued Operations (2)
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (4,071) (461) (459) (143)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (4,071) (461) (459) (143)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

 Koios Beverage Corp. (KBEVF) Appoints Former Molson Coors Global Brand Director Josh Luman to its Board of Directors

Koios Appoints Former Molson Coors Global Brand Director Josh Luman to its…

Green Thumb Industries Inc. (GTBIF) Announces Exercise of Extended Maturity Date of Senior Debt Facility

Green Thumb Industries Announces Exercise of Extended Maturity Date of Senior Debt…

$EAPH and BMV Medica Sign MOU Towards Exclusive Distribution

Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman’s…

Cara Therapeutics, Inc. (CARA) Reports Continuation of Phase 3 Trial of I.V. CR845

Cara Therapeutics Reports Continuation of Phase 3 Trial of I.V. CR845 in…